Experts Matter. Find Yours.

ChristianaCare Rated a High Performing Hospital for Maternity by U.S. News & World Report

ChristianaCare is the only health system in Delaware to earn the High Performing designation from U.S. News ChristianaCare has earned the highest award for maternity care that a hospital can achieve from U.S. News & World Report in its 2022-23 ratings for Best Hospitals for Maternity Care. Rated as a High Performing Hospital, ChristianaCare was the only health system in Delaware to earn this esteemed honor. Christiana Hospital at ChristianaCare’s Newark Campus is the only high-risk delivering hospital in the First State offering Level III neonatal intensive care. More than 6,100 babies are born at Christiana Hospital each year. The U.S. News Best Hospitals for Maternity Care methodology is based entirely on objective measures of quality, such as C-section rates in lower-risk pregnancies, newborn complication rates, exclusive breast milk feeding rates, early elective delivery rates and vaginal birth after cesarean (VBAC) rates, among other measures. “When we announced plans seven years ago to build the ChristianaCare Center for Women’s & Children’s Health, we affirmed our commitment to provide superior-quality care for women and infants in our region,” said Matthew Hoffman, M.D., MPH, FACOG, Marie E. Pinizzotto, M.D., Endowed Chair of Obstetrics and Gynecology at ChristianaCare. “This prestigious recognition is an affirmation that patients who choose to give birth at ChristianaCare will have access to the very best services and expertise to ensure a safe delivery and a healthy baby.” Just two years ago ChristianaCare opened the Center for Women’s & Children’s Health, an eight-story, approximately 400,000-square-foot tower at Christiana Hospital. The center uses the most up-to-date, evidence-based models of care, with improved integration of services and the space to offer innovative patient-centered care for mothers, babies and families. One of the most significant features of the new center is a state-of-the-art neonatal intensive care unit (NICU), featuring private rooms with sleep-in space for families. Christiana Hospital is one of the only hospitals in the United States to provide “couplet care” in the NICU, keeping the mother and baby together even if they both require medical care. This is based on a European model demonstrating that moms are more likely to breastfeed in this environment, which is particularly important in the early development of children. “We best achieve optimal health and flourish when we are able to begin our lives as healthy newborns,” said David Paul, M.D., chair of ChristianaCare’s Department of Pediatrics. “Building this transformative women’s and children’s hospital was a way to invest in the future of our community’s children. In addition to our outstanding caregivers and the care we provide within the walls of the hospital, this facility is a monumental step forward in enabling us to care for moms and babies, and we are delighted that U.S. News has recognized what a special place it is.” Other innovative features at the center include: Expanded labor and delivery suites. Private rooms for mothers and families after delivery. A spacious, multi-level Ronald McDonald Family Room to support families with infants who are in intensive care. Expanded OB/GYN emergency services area and new labor lounge. Separate admitting and discharge areas for the convenience of our patients. A tranquil family rooftop garden that provides spaces for play and relaxation. Vibrant sibling play spaces with interactive displays and artwork, and open community spaces for health education and programs. U.S. News’ annual evaluation is designed to assist expectant parents and their doctors in making informed decisions about where to receive maternity care. U.S. News evaluated nearly 650 hospitals that provide high-quality labor and delivery services for uncomplicated pregnancies for its 2022-2023 Best Hospitals for Maternity Care. Fewer than half of all hospitals that offer maternity care and participated in the survey received a High Performing designation. “When expectant parents are considering their options for welcoming a baby to the world, the Best Hospitals for Maternity Care are designed to help them identify hospitals that excel in delivering babies for uncomplicated pregnancies,” said Ben Harder, chief of health analysis and managing editor at U.S. News & World Report. “A hospital that has earned a High Performing designation may be a good option for parents, in consultation with their medical provider, to consider.” Excellence in Maternity Care Built on Experience and Research ChristianaCare’s Center for Women’s & Children’s Health includes Delaware’s most experienced maternity team, and it is also a significant research institution. Since opening, the Center for Women’s & Children’s Health participated in a significant study that found that treating mild chronic hypertension with medications is beneficial and safe for mother and baby. Published in The New England Journal of Medicine, the world’s foremost medical journal, the study has the potential to change the standard of care for some pregnant women, as it represented the first time that comprehensive, evidence-based data showed the benefits of treating mild forms of chronic hypertension during pregnancy. “Our commitment to research is a path to better caring for our community,” said Dr. Hoffman, a co-author in the study. About ChristianaCare Headquartered in Wilmington, Delaware, ChristianaCare is one of the country’s most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,299 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. It also includes the pioneering Gene Editing Institute. ChristianaCare is nationally recognized as a great place to work, rated by Forbes as the 2nd best health system for diversity and inclusion, and the 29th best health system to work for in the United States, and by IDG Computerworld as one of the nation’s Best Places to Work in IT. ChristianaCare is rated by Healthgrades as one of America’s 50 Best Hospitals and continually ranked among the nation’s best by U.S. News & World Report, Newsweek and other national quality ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.

ChristianaCare Names Its Breast Center: The Tatiana Copeland Breast Center

ChristianaCare has named its Breast Center The Tatiana Copeland Breast Center at the Helen F. Graham Cancer Center & Research Institute in recognition of Gerret and Tatiana Copeland’s generous financial support. The Copelands, local philanthropists and business entrepreneurs, provided a $1.2 million gift to the Graham Cancer Center in 2019 for breast cancer prevention and research for underrepresented women. Tatiana Copeland previously provided $800,000 to fund the purchase of two 3D mammography units. As a result of their philanthropic leadership, the Graham Cancer Center was one of the first facilities in the nation to offer 3D mammography. “ChristianaCare is deeply grateful to the Copelands for their generous support of the Helen F. Graham Cancer Center & Research Institute,” said Janice Nevin, M.D., MPH, ChristianaCare president and CEO. “They have made a tremendous difference in the lives of so many women in and around Delaware. We are deeply honored to name the Breast Center after Tatiana.” In a private event celebrating the naming, Dr. Nevin read a personal letter from President Joe Biden and First Lady Jill Biden that was sent to Tatiana about her support of the Breast Center. “Tatiana is a woman with extraordinary vision and a compassionate heart,” wrote President Biden. “As a breast cancer survivor, she has taken her pain and turned it into purpose, ensuring that all those who come in for testing at the Breast Center will receive extraordinary care. She has put lifesaving and life-altering care within the reach of those who need it most. And through it all, she has pushed for progress, fought for patients and kept hope alive.” “The Copelands share our commitment to providing our patients with the very best breast care, diagnosis and treatment,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “Their generous gifts have enabled women from Delaware and surrounding communities to receive expert, compassionate care right here at the Breast Center without ever having to leave the state. The Copelands have a way of discovering a need and then making the impossible possible.” “As longtime Graham Cancer Center supporters and as a breast cancer survivor myself who received wonderful treatment here, we are confident our investment in the Breast Center will continue to enable women to receive the same care that I did,” Tatiana Copeland said. “The atmosphere of the Breast Center is very comforting — like a nurturing hospital,” she said. “Everybody is very caring and attentive. Dr. Petrelli has created a team effort that is truly admirable. We hope our support inspires others to join us in the fight against cancer.” At The Tatiana Copeland Breast Center, patients are supported by an exceptional care team that includes radiologists, surgeons, radiation oncologists, genetic counselors and support staff. On-site capabilities include: 3D mammography. Digital mammography. Dedicated breast MRI. Breast ultrasound. Minimally invasive breast biopsies. Financial resources. Delaware’s first Center for Breast Reconstruction. According to the Delaware Division of Public Health, breast cancer is the most common cancer diagnosed among women in Delaware and the second leading cause of cancer death among women in the state after lung cancer. The Graham Cancer Center conducts community outreach to educate women about the importance of breast cancer detection and early prevention, including specially designed programs for underrepresented communities, including Black, Latinx and Asian women. “The Copelands’ ongoing generosity and support have helped us elevate the level of care at the Breast Center,” said Dia Williams, vice president of Philanthropy at ChristianaCare. “This gift will have an impact for generations to come.” To learn more about ChristianaCare’s philanthropy opportunities, visit https://christianacare.org/donors.

Aston University photonics expert elected as Fellow of Optica

• Professor Edik Rafailov is head of the Optoelectronics and Biomedical Photonics Research Group • He is a member of Aston Institute of Photonic Technologies, a world-leading photonics research centre • Optica is the leading organisation for researchers and others interested in the science of light. A photonics expert at Aston University has been elected as a Fellow of Optica (formerly OSA), Advancing Optics and Photonics Worldwide. Professor Edik Rafailov is head of the Optoelectronics and Biomedical Photonics Research Group in the College of Engineering and Physical Sciences at Aston University and a member of Aston Institute of Photonic Technologies (AIPT), one of the world’s leading photonics research centres. He was elected for his ‘contributions to novel gain media for semiconductor lasers at wavelengths from 750nanometres to1300nanometres’. Optica is the society dedicated to promoting the generation, application, archiving and dissemination of knowledge in the field of photonics. Founded in 1916, it is the leading organisation for scientists, engineers, business professionals, students and others interested in the science of light. Fellows are selected based on several factors, including outstanding contributions to business, education, research, engineering and service to Optica and its community. Satoshi Kawata, 2022 Optica president, said: “I am pleased to welcome the new Optica Fellows. These members join a distinguished group of leaders who are helping to advance the field optics and photonics. Congratulations to the 2023 Class.” Director of AIPT, Professor Sergei Turitsyn said: “I am delighted that Edik has received this prestigious fellowship. “AIPT has one more Optica Fellow, that is a high honour in the field of photonics. “Edik joined Aston University in 2014 and since then his research has contributed to the Institute’s world-leading position in the fields of fibre and semiconductor lasers and bio-medical photonics, making impact on industry, scientific communities and society.” Fellows are Optica members who have served with distinction in the advancement of optics and photonics. As they can account for no more than 10 percent of the total membership, the election process is highly competitive. Candidates are recommended by the Fellow Members Committee and approved by the Awards Council and Board of Directors. The new Optica Fellows will be honoured at the Society’s conferences and events throughout 2023.

How to keep up with continuous and sudden demand?

Learn about how the team at Grand River & St. Mary’s General Hospital are keeping up with demand for Radiology services using the RealTime Medical Teleradiology solution. Watch our interview with Dr. Darren Knibutat, Staff Radiologist at Grand River & St. Mary's General Hospital, to see how they manage a demanding workload, hold the line on costs and deliver improved patient care. Find the full interview here: https://youtu.be/lScHwliTnXY Visit our website: www.realtimemedical.com #Teleradiology #Radiology #DiagnosticImaging #PatientCare

Researchers awarded £2 million to develop drugs to prevent epileptic seizures in children

• Three-year research project to develop new drug treatments for childhood epilepsy • Scientists will test new treatment on pieces of living brain tissue • The research is a collaboration between Aston University, Bristol University and Jazz Pharmaceuticals. Scientists at Aston University have started work on a project that will look for new drug treatments to prevent the onset of childhood epilepsy. The three-year Medical Research Council (MRC) funded project is a collaboration led by researchers in the College of Health and Life Sciences at Aston University, partnered with Bristol University and Jazz Pharmaceuticals. They have been awarded £2 million to explore how epilepsy becomes established in the brain and how this process might be prevented. The researchers will test new drugs in the human brain, using samples of living tissue taken from children with difficult to treat epilepsies who have had to have brain surgery. Epilepsy is a brain disease which is characterised by seizures. As Professor Gavin Woodhall, lead researcher and co-director of Aston Institute of Health and Neurodevelopment, explains: “Seizures are periods of time when networks of brain cells are too active and are uncontrollably excited and spiking. If uncontrolled excitation spreads to brain regions that control movement, then too many brain cells are ‘talking at the same time’ and we can see seizures as changes in movement such as jerks and twitches.” Upon receiving the grant, Professor Woodhall said: “We will be able to study epilepsy in such detail that we hope to be able to treat the problems that underly epilepsy and not just the seizures themselves. And this could help pave the way to prevent epilepsy from developing in children at all. “Essentially we want to find a treatment that stops the brain from being able to establish epilepsy after the first seizure - via a new drug treatment. We will be testing a known drug and a new drug to see if the drug can do this.” As part of the research for this project the scientists will look at how different amounts of epileptic activity in the brain can alter the brain’s excitability. The researchers predict that if there are a lot of seizures, the synapses in the brain will decrease their activity and brain cells will become more likely to spike. Professor Woodhall added: “This is why we will test antiepileptic drugs, and new drugs designed to interfere with homeostatic scaling - which is a form of plasticity, in which the brain responds to chronically elevated activity in a neural circuit with negative feedback, allowing individual neurons to reduce their overall action potential firing rate. “By interfering with homeostatic scaling we will be able to see if they can prevent seizures from developing or reducing their intensity.” The research will allow Professor Woodhall and his team to be able to record the life history of the disease. This is something which has not been done before in this level of detail and it is predicted it will help to shed light on how epilepsy initially develops in the brain. Following on from the three-year project the team will move into drug development and then clinical trial. For more information about research being undertaken at AIHN please go to our website. If you are interested in the courses we have available in this area please go to our course pages.

How do ER Doctors Use the RealTime Medical System?

Learn about how Dr. Colin L. Taylor uses workload balancing and other unique features of the RealTime Medical’s software to improve collaboration and support reading for multiple sites simultaneously. Find the full interview here: https://youtu.be/z-Fpm1daaL8 Visit our website: www.realtimemedical.com #radiology #diagnosticimaging #patientcare

Partnership with Hims & Hers Expands In-Person Healthcare Access in Four States

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, and one of the nation’s premier health systems, ChristianaCare, today announced a partnership that will expand access to healthcare services and create a more seamless care journey for patients. The partnership will benefit customers in Delaware, Maryland, New Jersey and Pennsylvania, and expands the Hims & Hers’ partnership network with providers to now include 10 states and Washington D.C. Hims & Hers offers treatments for a broad range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. This collaboration allows licensed medical providers on the Hims & Hers platform to connect patients with ChristianaCare’s industry leading Center for Virtual Health and extensive primary and specialty care provider network when appropriate. Referrals may occur if a patient presents with a complex medical history, requires additional in-person follow up or evaluation, or needs care for a condition that the Hims & Hers platform does not support. This collaboration advances the Hims & Hers mission to expand access to high-quality, convenient and affordable care by adding another high-quality health system to its growing network of provider relationships. “ChristianaCare stands for excellence in healthcare and is rated as one of the best hospitals in America, making them an excellent and trusted partner in ensuring a high-quality care experience throughout a consumer’s journey,” said Hims & Hers Chief Operating Officer Melissa Baird. “Healthcare consumers today want easy-to-use, on-demand access to high-quality care both digitally and in-person, so our proprietary platform, coupled with partnerships such as ChristianaCare, help them smoothly navigate more of their healthcare needs.” ChristianaCare is one of the country’s most dynamic healthcare organizations that is committed to improving health outcomes, increasing access to high-quality care and lowering the costs for patients. Its Center for Virtual Health makes health care accessible and convenient, available 24/7 through computer, tablet or smartphone. By partnering with Hims & Hers, ChristianaCare gains access to a broader patient population for its Center for Virtual Health and extensive network of primary care, outpatient services, and specialty care services, including its comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. “ChristianaCare is thrilled to partner with Hims & Hers to make high-quality health care available to its customers who have complex needs or need additional services that Hims & Hers does not provide,” said Sharon Anderson, MS, RN, FACHE, ChristianaCare’s chief virtual health officer and president of ChristianaCare’s Center for Virtual Health. “At ChristianaCare, our Center for Virtual Health provides personalized health care consultations that are immediate, coordinated, continuous and available 24/7, delivering value to our patients and making a positive impact on health,” she said. This partnership with ChristianaCare builds upon established relationships with other high-quality providers, including Carbon Health in California; Oschner in Louisiana; Mount Sinai Health System in New York City; and Privia in the District of Columbia, Georgia, Maryland, Texas, and Virginia. ChristianaCare will provide support to select counties within Delaware, New Jersey, Pennsylvania and Maryland.

How workload balancing enables high-efficiency reading for multiple sites?

Learn about how Dr. Colin L. Taylor uses workload balancing and other unique features of the RealTime Medical’s software to improve collaboration and support reading for multiple sites simultaneously. Learn more: https://realtimemedical.com/software-solutions/ See more Customer Stories: https://realtimemedical.com/about-realtime-medical/what-customers-are-saying/ #radiology #peerlearning #diagnosticimaging

Why was teleradiology right for our group practice?

Learn about how Dr. Darren Knibutat and the team at Grand River & St. Mary’s General Hospital are implementing RealTime’s radiology collaboration services to help manage a demanding workload, hold the line on costs and deliver improved patient care. Learn more here: https://realtimemedical.com/radiology-services/ See more Customer Stories: https://realtimemedical.com/about-realtime-medical/what-customers-are-saying/ #radiology #teleradiology #diagnosticimaging

What We Experience - Turnaround Time Within Minutes

Learn how radiology collaboration services have improved ER efficiency and patient experience from Tabitha Kearney, VP Clinical Services, Deep River & District Hospital. Learn more here: https://realtimemedical.com/radiology-services/ See more Customer Stories: https://realtimemedical.com/about-realtime-medical/what-customers-are-saying/ #radiology #teleradiology #diagnosticimaging